Where to Inject Wegovy

Mounjaro (Tirzepatide) has become a popular choice for weight loss, especially among women looking for a reliable way to manage cravings and reduce their appetite. Known for its ability to help regulate blood sugar levels and mimic hormones that control hunger, Mounjaro often provides welcome support for those who’ve struggled with traditional weight-loss methods.

Yet, many women taking Mounjaro still experience moments of unexpected hunger a frustrating experience that can lead to questions and concerns. After all, isn’t the medication supposed to make you feel less hungry? If you’ve been wondering, “Why do I still feel hungry while on Mounjaro?” you’re not alone.

Research suggests that around 30% of individuals on medications like Mounjaro report occasional hunger, particularly in the early stages of treatment. It’s normal to feel frustrated by these unexpected cravings. But remember, this journey is unique for every individual, and experiencing hunger doesn’t mean the medication isn’t working or that your efforts aren’t paying off. Rather, it’s an opportunity to understand your body’s responses, make adjustments, and find solutions that complement your use of Mounjaro.

How Mounjaro Works

Mounjaro, known generically as tirzepatide, is a novel medication that functions as a GLP-1 receptor agonist and also activates the GIP receptor. This dual-action mechanism sets it apart from other weight loss medications, such as semaglutide, which primarily targets the GLP-1 receptor. Understanding how Mounjaro works is essential for appreciating its role in appetite regulation and weight loss.

Mechanism of Action as a GLP-1 Receptor Agonist

Mounjaro operates by mimicking the actions of incretin hormones, specifically glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones play a crucial role in glucose metabolism and appetite regulation.

1. Activation of GLP-1 and GIP Receptors: By activating both GLP-1 and GIP receptors, Mounjaro enhances insulin secretion in response to meals while simultaneously inhibiting glucagon release, which helps lower blood sugar levels. This mechanism is particularly beneficial for individuals with type 2 diabetes but also supports weight loss by regulating appetite.
2. Appetite Suppression: Clinical studies have demonstrated that Mounjaro significantly reduces appetite. In the SURMOUNT-3 trial, participants treated with tirzepatide experienced an average weight loss of 26.6% over 84 weeks, highlighting its effectiveness in promoting satiety and reducing food intake. This reduction in appetite is achieved through signalling pathways that inform the brain when the body is full, allowing individuals to consume smaller portions without feeling deprived.

Regulation of Appetite and Increased Feelings of Fullness‍

Mounjaro's ability to regulate appetite and enhance feelings of fullness is central to its weight loss efficacy:

• Satiety Signalling: When tirzepatide is administered, it stimulates areas in the brain responsible for satiety, effectively sending signals that indicate fullness after consuming smaller amounts of food. This leads to decreased caloric intake over time, contributing to weight loss.
• Slower Gastric Emptying: Mounjaro also slows gastric emptying, which prolongs the sensation of fullness after meals. This physiological change helps prevent rapid spikes in hunger and cravings that can lead to overeating.
• Clinical Evidence: In trials involving participants with obesity or overweight conditions, those receiving tirzepatide reported significant reductions in hunger levels and cravings compared to placebo groups. 

Why Might You Still Feel Hungry on Mounjaro?

While Mounjaro is designed to suppress appetite and facilitate weight loss, some individuals may still experience feelings of hunger. This can be attributed to various factors, including individual variation in medication response, insufficient dosing, lifestyle factors, and underlying medical conditions.

1. Individual Variation

Response to Medications

Individuals respond differently to medications like Mounjaro due to a range of biological factors. Clinical studies have shown that while many users experience significant appetite suppression, others may not respond as effectively. 

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2 Trial)

In the SURMOUNT-2 trial, participants treated with Mounjaro lost an average of 15% of their body weight over 72 weeks; however, some participants reported persistent hunger despite being on the medication. This variability can arise from differences in how the body metabolises the drug and responds to its effects.

Genetic and Metabolic Factors

Genetic predispositions can significantly influence how individuals experience hunger and satiety. Variations in genes associated with appetite regulation, such as those affecting GLP-1 receptor sensitivity, may lead to differences in how effectively Mounjaro suppresses appetite. 

Additionally, metabolic factors such as basal metabolic rate (BMR) can impact hunger levels; individuals with a higher BMR may experience increased hunger even when taking appetite-suppressing medications. A study indicated that genetic factors could account for about 30% of the variability in weight loss outcomes among participants using GLP-1 receptor agonists.

2. Lifestyle Factors

Role of Diet and Exercise

Lifestyle choices play a significant role in the overall effectiveness of Mounjaro for weight loss. A balanced diet rich in whole foods, combined with regular physical activity, is essential for achieving optimal results. Studies indicate that participants who engaged in structured lifestyle interventions alongside medication experienced greater weight loss than those relying solely on pharmacotherapy.

Importance of Balanced Diet and Regular Physical Activity

Incorporating healthy eating habits and exercise into daily routines can help mitigate feelings of hunger while on Mounjaro. For example, consuming high-fibre foods can promote satiety and reduce overall caloric intake. Additionally, regular physical activity has been shown to enhance metabolic health and improve appetite regulation. Research suggests that individuals who maintain a caloric deficit through diet and exercise alongside Mounjaro treatment can achieve better weight management outcomes.

4. Underlying Medical Conditions

Certain medical conditions can contribute to persistent feelings of hunger even when using Mounjaro:

• Hypothyroidism: This condition can slow metabolism and increase feelings of fatigue and hunger due to hormonal imbalances.
• Polycystic Ovary Syndrome (PCOS): Women with PCOS often experience insulin resistance, which can lead to increased appetite and difficulty managing weight despite treatment efforts.

These underlying conditions may necessitate additional interventions or adjustments in treatment strategies to effectively manage hunger.

Strategies to Manage Hunger on Mounjaro

Managing hunger while using Mounjaro is crucial for optimising weight loss outcomes. Here are several effective strategies that incorporate mindful eating, dietary adjustments, lifestyle modifications, and professional guidance.

1. Mindful Eating

Encouraging Slow, Intentional Eating

Practising mindful eating involves taking the time to enjoy meals and being fully present during the eating experience. This approach can enhance awareness of hunger and fullness cues, helping individuals recognize when they are satisfied. Research indicates that slow eating can lead to a reduction in overall food intake. A study found that individuals who ate slowly consumed 70 fewer calories per meal compared to those who rushed their meals.

Paying Attention to Hunger and Fullness Cues

By focusing on internal signals of hunger and satiety, individuals can better regulate their food intake. Mindful eating encourages people to assess their hunger levels before, during, and after meals, which can help prevent overeating and improve satisfaction with smaller portions.

2. Dietary Strategies

Balanced Diet Rich in Protein, Fiber, and Healthy Fats

A balanced diet is essential for managing hunger effectively while on Mounjaro. Incorporating high-protein foods, such as lean meats, fish, eggs, legumes, and low-fat dairy products, can enhance feelings of fullness. Protein has been shown to increase satiety more than carbohydrates or fats; one study found that participants consuming a high-protein diet reported 50% greater feelings of fullness compared to those on a standard diet.

Fibre-rich foods, such as fruits, vegetables, whole grains, and legumes, also play a critical role in appetite control. Fibre promotes satiety by adding bulk to meals without significantly increasing caloric intake. For example, a study demonstrated that increasing fibre intake led to a 10% reduction in overall caloric consumption.

Healthy fats from sources like avocados, nuts, seeds, and olive oil can further enhance satiety. These fats take longer to digest and can help maintain energy levels throughout the day.

Frequent Smaller Meals and Snacks

Consuming smaller meals and snacks throughout the day can help manage hunger effectively. Research suggests that individuals who eat more frequently may experience better appetite control and less intense hunger between meals. A study in the Journal of Nutrition indicated that participants who consumed smaller, more frequent meals reported lower levels of hunger compared to those who ate larger meals less often.

2. Role of Hydration

Staying adequately hydrated is essential for managing hunger. Drinking water before meals can promote feelings of fullness and reduce overall caloric intake. 

A study found that participants who drank two cups of water before each meal lost 44% more weight over 12 weeks compared to those who did not.

3. Regular Physical Activity

Engaging in regular physical activity is crucial for weight management and can help regulate appetite. Exercise has been shown to influence hormones related to hunger and satiety positively. 

Clinical Insights

A meta-analysis published in Sports Medicine found that physical activity can reduce levels of ghrelin (the hunger hormone) while increasing levels of peptide YY (a hormone that promotes fullness).

4. Benefits of Stress Management Techniques

Stress can significantly impact appetite regulation, often leading to increased cravings for unhealthy foods. Implementing stress management techniques such as mindfulness meditation, yoga, or deep-breathing exercises can help mitigate stress-induced eating behaviours. A systematic review in Health Psychology found that mindfulness-based interventions significantly reduced emotional eating among participants.

Consult with a Healthcare Professional

Consulting with a healthcare provider is essential for tailoring weight loss strategies while using Mounjaro. Healthcare professionals can provide personalised advice on dietary changes and lifestyle modifications that best suit individual needs.

If persistent feelings of hunger occur despite adherence to these strategies, healthcare providers may consider dosage adjustments or alternative treatments. Clinical studies have shown that higher doses of tirzepatide result in greater appetite suppression; for instance, participants receiving the maximum dose (15 mg) experienced an average weight loss of 26.6% over 84 weeks compared to lower doses.

Conclusion

Feeling hungry while on Mounjaro can be a discouraging experience, especially when you’re putting in the effort to stay consistent with your weight-loss plan. Understanding the potential reasons behind persistent hunger and adopting some targeted strategies can help you stay on track and make the most of your journey with Mounjaro. 

Small changes—like focusing on nutrient-dense, high-fibre foods, staying hydrated, managing stress, and including protein in each meal—can help manage hunger effectively. Additionally, setting realistic expectations can make all the difference. Mounjaro is a tool designed to support your weight-loss journey, but it works best alongside a balanced approach to eating, movement, and lifestyle habits.

Still feeling hungry on Mounjaro? You're not alone, and there are ways to manage it. Our experts can help you understand why this happens and how to adjust for better results. Contact us today at SheMed for personalised guidance and support on your weight loss journey!

Frequently Asked Questions

1. Does eating certain foods reduce hunger more effectively on Mounjaro?
   Yes, high-fibre foods, lean protein, and healthy fats can help you feel fuller for longer. Including these in each meal can make a noticeable difference in managing hunger.
2. Will my hunger reduce if I increase the Mounjaro dose?
   Only your healthcare provider should determine if a dose adjustment is necessary. Increasing the dose on your own can lead to side effects and may not directly reduce hunger.
3. Can exercise make me feel hungrier on Mounjaro?
   Physical activity can increase appetite, especially after intense workouts. Incorporating light to moderate exercise, staying hydrated, and eating balanced meals can help manage this effect.
4. Is it normal to feel hungry on Mounjaro, or does it mean the medication isn’t working?
   Experiencing hunger on Mounjaro doesn’t mean the medication isn’t working. Hunger can still arise, especially during certain times of day or if you’re stressed, tired, or not eating enough balanced meals.
5. Are there ways to manage hunger while taking Mounjaro?
   Drinking plenty of water, eating fibre-rich meals, and spacing meals throughout the day can help manage hunger. Reducing refined carbs and including protein in every meal are also helpful strategies.
6. What should I do if my hunger is affecting my weight-loss progress?
   If hunger is hindering your progress, speak with your healthcare provider. They can help assess potential dietary adjustments, behavioural strategies, or a tailored plan to support your goals effectively.
7. Can Mounjaro be combined with other weight-loss strategies to reduce hunger?
   Yes, Mounjaro often works well alongside healthy eating, exercise, and stress management. Combining these approaches can make hunger less frequent and support long-term success.
8. Is feeling less hungry on Mounjaro a sign that it’s working?
   Yes, reduced hunger is generally an indicator of Mounjaro’s effectiveness. As your body adapts, hunger may decrease, helping you feel fuller and more in control of your eating habits.

References

1. D'Souza, A. M., & Kahn, S. E. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: The SURMOUNT-3 phase 3 trial. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/36751934/
2. Kahn, S. E., & Cooper, M. E. (2012). Eating & physical activity to lose or maintain weight. National Institute of Diabetes and Digestive and Kidney Diseases. https://pubmed.ncbi.nlm.nih.gov/22776039/
3. Michalak, J., & Möller, A. (2021). Mindful eating: A review of how the stress-digestion-mindfulness triad may modulate and improve gastrointestinal and digestive function. Journal of Gastroenterology and Hepatology. https://pubmed.ncbi.nlm.nih.gov/36751934/‍
4. McGarrigle, C., & Leach, J. (2021). Mindfulness-based positive psychology interventions: A systematic review. BMC Psychology, 9(1), 1-15. https://doi.org/10.1186/s40359-021-00510-0

Managing type 2 diabetes can be a complex and often frustrating journey, especially for women balancing health with the demands of daily life. For those struggling to stabilise blood sugar levels, reduce complications, and achieve weight loss, every new treatment can seem like a potential turning point. This is where semaglutide, a GLP-1 receptor agonist, has shown significant promise. 

Originally developed as a treatment for type 2 diabetes, semaglutide works by enhancing the body’s insulin production and helping to regulate blood sugar levels more effectively. The GLP-1 receptor agonist action promotes insulin release when blood sugar levels rise, which reduces the chance of dangerous blood sugar spikes and helps manage diabetes more predictably. 

Beyond its blood sugar control benefits, semaglutide has also been shown to assist in weight loss. Weight gain is often tied to insulin resistance and other metabolic issues associated with diabetes. Achieving and maintaining a healthy weight can be instrumental in controlling blood sugar in women with type-2 diabetes. Semaglutide has become a topic of interest due to its dual benefits for diabetes patients. It offers a valuable advantage for those looking to achieve both diabetes management and a healthier weight.

The Role of Incretin Hormones in Blood Sugar Regulation

Incretin hormones, particularly glucagon-like peptide-1 (GLP-1), play a crucial role in regulating blood sugar levels. Released from the intestines in response to food intake, GLP-1 enhances insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are elevated. This mechanism helps to prevent hypoglycemia, as insulin is released appropriately according to the body's needs.

Additionally, GLP-1 inhibits glucagon secretion from alpha cells of the pancreas. Glucagon typically acts to raise blood glucose levels by promoting glycogenolysis and gluconeogenesis in the liver. By reducing glucagon levels, GLP-1 further contributes to lowering blood sugar levels after meals. Furthermore, GLP-1 slows gastric emptying, which helps moderate the rate at which glucose enters the bloodstream following a meal, thus aiding in postprandial glycemic control.

Mechanisms of Action of Semaglutide: How it mimics GLP-1 hormone

With a structural similarity of 94% to human GLP-1, semaglutide binds to and activates the GLP-1 receptor, leading to several beneficial effects on glucose metabolism and appetite regulation.

Semaglutide's mechanisms of action can be categorised into four primary functions:

• Slowing Gastric Emptying: Semaglutide delays gastric emptying, which reduces the speed at which food and glucose enter the bloodstream. This effect helps maintain more stable blood sugar levels after meals by preventing rapid spikes in glucose.
• Increasing Insulin Secretion: By activating GLP-1 receptors on pancreatic beta cells, semaglutide enhances insulin secretion in response to elevated blood glucose levels. This action is particularly important for individuals with type 2 diabetes, as it helps improve glycemic control without risking hypoglycemia when blood glucose levels are normal or low.
• Reducing Glucagon Secretion: Semaglutide also suppresses glucagon release from pancreatic alpha cells. This reduction is critical because it decreases hepatic glucose production, further contributing to lower blood sugar levels during and after meals.
• Enhancing Satiety and Reducing Appetite: Semaglutide influences central nervous system pathways that promote feelings of fullness (satiety) and reduce appetite. By acting on receptors in the hypothalamus, semaglutide helps decrease food intake and cravings, which can lead to weight loss an important aspect of managing type 2 diabetes and obesity.

Clinical Studies Supporting Semaglutide's Efficacy

Several clinical trials have demonstrated the effectiveness of semaglutide in managing type 2 diabetes and promoting weight loss:

• SUSTAIN Trials: These trials consistently showed that semaglutide significantly reduces haemoglobin A1c (HbA1c) levels compared to placebo and other diabetes medications. For instance, SUSTAIN 6 indicated a reduction in major cardiovascular events among patients treated with semaglutide.
• Weight Management Studies: In studies involving obese individuals without diabetes, semaglutide led to significant weight loss compared to placebo groups. The drug's ability to enhance satiety and reduce appetite was key factors contributing to this outcome

The Link Between Type 2 Diabetes and Weight Gain

Type 2 diabetes (T2D) and obesity are closely interconnected, often creating a vicious cycle that exacerbates both conditions. Individuals with T2D frequently experience weight gain due to several factors:

• Insulin Resistance: T2D is characterised by insulin resistance, which can lead to increased fat storage as the body struggles to utilise glucose effectively. Elevated insulin levels, a result of the pancreas producing more insulin to overcome resistance, promote fat accumulation, particularly in the abdominal area.
• Hormonal Changes: The hormonal environment in individuals with T2D is altered, affecting appetite regulation and metabolism. For instance, elevated levels of glucagon and decreased levels of incretin hormones like GLP-1 can lead to increased hunger and reduced satiety.
• Sedentary Lifestyle: Many individuals with T2D may adopt a sedentary lifestyle due to fatigue or other health complications, further contributing to weight gain.

This interplay between T2D and obesity  not only complicates management strategies but also increases the risk of cardiovascular diseases, hypertension, and other metabolic disorders.

Safety and Side Effects

Semaglutide is generally well-tolerated, but it can cause side effects. Common adverse effects include:

• Gastrointestinal Issues: Nausea, vomiting, diarrhoea, and constipation are frequently reported. In clinical trials, up to 20% of participants experienced nausea during the initial weeks of treatment. These symptoms often diminish over time as the body adjusts.
• Hypoglycemia: When used in conjunction with other diabetes medications (like insulin or sulfonylureas), there is an increased risk of low blood sugar (hypoglycemia) due to the combined effects of these drugs. Symptoms of hypoglycemia include shakiness, sweating, confusion, and in severe cases, loss of consciousness.
• Pancreatitis: There is a potential risk of pancreatitis associated with semaglutide use. Clinical studies have reported cases of acute pancreatitis in patients using GLP-1 receptor agonists.

Potential Drug Interactions

Semaglutide has numerous drug interactions that women should consider:

• Major Interactions: Semaglutide interacts with 265 known drugs, including anticoagulants (e.g., warfarin) and other diabetes medications like sulfonylureas and insulin. These combinations can heighten the risk of hypoglycemia or bleeding complications.
• Moderate Interactions: Certain medications may alter the absorption or effectiveness of semaglutide due to its effect on gastric emptying. For example, oral contraceptives may have altered absorption when taken concurrently with semaglutide.

Conclusion

Semaglutide offers a promising dual approach for managing type 2 diabetes and supporting weight loss, particularly for women balancing complex health needs. By mimicking natural GLP-1 hormones, it helps regulate blood sugar, enhances insulin release, reduces appetite, and promotes weight loss. Clinical trials show significant benefits in both glycemic control and cardiovascular outcomes. While generally well-tolerated, users should be aware of potential side effects and drug interactions. Consulting a healthcare professional is essential to determine if semaglutide is the right fit for individual needs. For many, semaglutide represents a valuable step toward better diabetes management and a healthier lifestyle.

If you have any questions regarding using semaglutide for weight loss then please do not hesitate to reach out to us at SheMed for personalised support and guidance. Note* - At SheMed, we prescribe GLP-1 medications strictly for weight loss and do not offer treatment to individuals taking insulin or other type 2 diabetes medications that may interact.

Frequently Asked Questions

1. How long does it take to see improvements in blood sugar control with semaglutide?

Many people report improved blood sugar control within the first few weeks of starting semaglutide. However, the full effect may take several months as your body adjusts to the medication. Regular monitoring with your healthcare provider will help track progress.

2. Will I definitely lose weight on semaglutide?

Weight loss with semaglutide is common, but individual results vary. Studies have shown that about 70% of individuals experience significant weight loss, which is generally an added benefit rather than a guaranteed outcome. It works best when combined with a balanced diet and regular physical activity.

3. Is semaglutide safe for long-term use?

Semaglutide is considered safe for long-term use under medical supervision. Clinical trials have demonstrated its effectiveness and safety over extended periods, but your healthcare provider can help determine if it’s the right option for your long-term diabetes and weight management.

4. Are there any common side effects I should be aware of?

The most common side effects of semaglutide include mild nausea, gastrointestinal discomfort, and occasional headaches. These side effects typically lessen as your body adjusts to the medication. If side effects persist, it’s important to consult your healthcare provider for guidance.

5. How is semaglutide administered, and can I take it at home?

Semaglutide is usually taken as a once-weekly injection. Most patients can administer it at home after receiving guidance from a healthcare professional, making it a convenient option for many people with busy schedules.

6. Can I continue with my current diet and lifestyle while taking semaglutide?

Although semaglutide aids in blood sugar and weight management, making adjustments to your diet and lifestyle can enhance its effectiveness. Incorporating a balanced diet, regular physical activity, and healthy lifestyle choices will improve results and support overall health.

References

1. National Center for Biotechnology Information. (2022). Physiology, GLP-1 receptor agonists. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK603723/
2. Frontiers. (n.d.). Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity. Frontiers in Endocrinology. Retrieved from Frontiers
3. Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., ... & Buse, J. B. (2017). Cardiovascular safety and benefits of semaglutide in patients with type 2 diabetes: Findings from SUSTAIN 6 and PIONEER 6. Diabetes, Obesity and Metabolism, 19(9), 1200–1209. Retrieved from ResearchGate
4. Imeryüz, N., & Yazıcı, D. (2012). Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials. PubMed. https://pubmed.ncbi.nlm.nih.gov/22776039/
5. ‍Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Ahrén, B. (2021). Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Obesity (Silver Spring), 29(3), 311-319. PubMed. https://pubmed.ncbi.nlm.nih.gov/